
Buy GDF-8 (Myostatin) Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis. A batch-specific Certificate of Analysis is included with every order.

Buy GDF-8 (Myostatin) Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis. A batch-specific Certificate of Analysis is included with every order.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Included
Every batch
Ships Next Day
Order before midnight. Dispatched tomorrow with cold-chain packaging
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Included
Every batch
Ships Next Day
Order before midnight. Dispatched tomorrow with cold-chain packaging
GDF-8 (Growth Differentiation Factor 8), also known as Myostatin, is a recombinant protein belonging to the transforming growth factor-beta (TGF-beta) superfamily. The mature bioactive form exists as a disulfide-linked homodimer with an approximate molecular weight of 25,000 g/mol, comprising two 109-amino acid monomers. Each monomer contains the canonical seven-cysteine motif common to TGF-beta superfamily members. Produced via recombinant expression in E. coli, Myostatin signals through activin type II receptors (ActRIIA and ActRIIB) and is one of the most extensively studied negative regulators of skeletal muscle mass in preclinical research.
GDF-8 has been extensively investigated in preclinical musculoskeletal biology and metabolic research. Published in vitro studies in primary human myotube and C2C12 myoblast cell preparations have investigated GDF-8’s receptor binding characteristics at ActRIIB and downstream SMAD2/3 phosphorylation cascades, documenting myostatin-mediated inhibitory signalling and suppression of myoblast differentiation and myotube growth parameters under controlled experimental conditions [1]. The observation that targeted disruption of the GDF-8 gene in rodent models produces widespread increases in skeletal muscle mass has made Myostatin a key reference compound in studies examining muscle homeostasis, satellite cell quiescence, and the balance between anabolic and catabolic signalling within the TGF-beta pathway. Research has also examined GDF-8’s interaction with endogenous antagonists including Follistatin, with published rodent transgenic model studies documenting that Follistatin-mediated antagonism of myostatin activity produces widespread skeletal muscle increases consistent with those observed following targeted gene disruption, characterising the molecular determinants of ligand-antagonist engagement within the GDF-8 regulatory axis [2].
GDF-8 is manufactured in a cGMP compliant laboratory to a guaranteed purity of 98% or above. Every batch is independently tested using HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available on request.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Editorial Team

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed and approved 14 June 2026
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Select Size
Buy 5+ vials to unlock discounts
Quality Guaranteed
Every batch is HPLC-tested to ≥99% purity. Certificate of Analysis and MSDS available with every order.
